v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Dec. 31, 2024
Operating Activities:        
Net loss $ (120,246) $ (55,134) $ (251,410) $ (179,579)
Adjustments to reconcile net loss to net cash (used) in / provided by operating activities:        
Common stock issued for consulting services - amortization 4,507
Changes in operating assets and liabilities:        
Trade accounts receivable 71,684 (14,727) 11,439
Inventories 28,373 10,393 (20,067)
Loan origination fee     (11,700)
Accounts payable and accrued expenses (52,792) (44,003) 40,447 (947)
Advance deposits (1,346) 9,822 16,018 (2,661)
Sales taxes payable (receivable) (791) 9,145 11,568 (9,145)
Net cash (used) in / provided operating activities (70,611) (84,504) (192,005) (204,031)
Investing Activities:        
Net cash provided by investing activities
Financing Activities:        
Due to related party - CEO 23,000 12,512
Loans related parties 24,500 40,000
Short term loan payable     87,046
Line of credit 50,450 54,250 165,500
Net cash provided by financing activities 47,500 50,450 193,808 165,500
Net decrease in cash (23,111) (34,054) 1,803 (38,531)
Cash, beginning of period 47,382 45,579 45,579 84,004
Cash, end of period 24,271 11,525 47,382 45,579
Supplemental disclosure of cash flow information        
Cash paid for interest 20,744 4,326
Cash paid for taxes
Non-cash Operating and Financing Activities:        
Issuance of Common Shares for Services 117,500    
Right of Use Asset and Operating Lease $ 172,038